13 news items
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cell Targeting Bispecific Antibody for Mesothelin-expressing Cancers
ZYME
17 Jun 24
of Zymeworks. "ZW171's unique design is intended to address the limitations of current bispecific T-cell engagers by enhancing tumor selectivity
Navigating 6 Analyst Ratings For Zymeworks
ZYME
6 Jun 24
diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME
ZYME
24 Apr 24
and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME
ZYME
20 Apr 24
of its officers and/or directors have engaged in securities fraud
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME
ZYME
16 Apr 24
and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices
xhjr8tf
ZYME
12 Apr 24
of its officers and/or directors have engaged in securities fraud
g5yrz
ZYME
8 Apr 24
and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices
7jxw50361vp4 dfc
ZYME
8 Apr 24
candidates and their pipeline advancement. TriTCE Co-Stim: A next generation trispecific T cell engager platform with integrated
i9fn2o2t93iy6uv0cin5u9ff1ot1rnjqjvka0ba5bydxmf
ZYME
4 Apr 24
of its officers and/or directors have engaged in securities
7d4otisw e206zdo1q
ZYME
4 Apr 24
of its officers and/or directors have engaged in securities
2efyjngnrils1f8dsgfywmazg do5
ZYME
3 Apr 24
of Zymeworks stockholders. Our investigation concerns whether Zymeworks has violated the federal securities laws and/or engaged in other unlawful business
ao1yes49ctgikpyc3z4h1oxppfcq5pb io7a2k
ZYME
2 Apr 24
concerns whether Zymeworks and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices
px03xsqb1c
ZYME
1 Apr 24
and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices
- Prev
- 1
- Next